Effect of the L-arginine-nitric oxide pathway on human placental vascular tone and corticotropin-releasing hormone secretion

Hypertension in Pregnancy

Volumn 16, Issue 3, 1997, Pages 367-378

  Leitch, Ian M ^a   Roe, Catherine M ^a   Walters, William A W ^a   Smith, Roger ^a   Boura, Alan L A ^a  

^a UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

Blood flow; Corticotropin releasing hormone; L arginine; Nitric oxide; Placenta

Indexed keywords

ARGININE; CORTICOTROPIN RELEASING FACTOR; NITRIC OXIDE;

ADULT; ARTERIAL PRESSURE; ARTICLE; BLOOD VESSEL TONE; FEMALE; FETUS; HEMODYNAMICS; HUMAN; IMMUNOREACTIVITY; PLACENTA; RADIOIMMUNOASSAY; UMBILICAL CORD BLOOD; VASCULAR RESISTANCE;

EID: 0030670685     PISSN: 10641955     EISSN: None     Source Type: Journal    
DOI: 10.3109/10641959709031645     Document Type: Article

References (46)

1. Knowles RG, Moncada S. Nitric oxide synthases in mammals. Biochem J 1994;298: 249-58.
2. Conrad KP, Joffe GM, Krusznya H, Krusznya R, Rochelle LG, Smith RP, et al. Identification of increased nitric oxide biosynthesis during pregnancy in rats. FASEB 1993;7:566-71.
3. Kopp L, Paradiz G, Tucci JR. Urinary excretion of cyclic 3′,5′-adenosine monophosphate and cyclic 3′,5′-guanosine monophosphate during and after pregnancy. J Clin Endocrinol Metab 1977;44:249-58.
4. Busse R, Mulsch A, Fleming I, Hecker M. Mechanisms of nitric oxide release from the vascular endothelium. Circulation 1993;87:V18-25.
5. Myatt L. Control of vascular resistance in the human placenta. Placenta 1993;13: 329-41.
6. Boura ALA, Walters WAW, Read MA, Leitch IM. Autacoids and control of human placental blood flow. Clin Exp Pharmacol Physiol 1994;21:737-48.
7. Roberts JM, Taylor RN, Goldfien A. Clinical and biochemical evidence of endothelial cell dysfunction in the pregnancy syndrome preeclampsia. Am J Hyperten 1991;4: 700-8.
8. Lyall L, Greer IA. The vascular endothelium in normal pregnancy and pre-eclampsia. Rev Reprod 1996;1:107-16.
9. Brown MA. The physiology of pre-eclampsia. Clin Exp Pharmacol Physiol 1995; 22:781-91.
10. Brennecke SP, Dilulio JL, Gude NM, King RG. Nitric oxide synthase activity of preterm human placental tissue is reduced in pre-eclampsia. Placenta 1994;15:A6.
11. Pinto A, Sorrentino R, Sorrentino P, Guerritore T, Miranda L, Biondi A, et al. Endothelial-derived relaxing factor released by endothelial cells of human umbilical vessels and its impairment in pregnancy-induced hypertension. Am J Obstet Gynecol 1991;164:507-13.
12. Fickling SA, Williams D, Vallance P, Nussey SS, Whitely GS. Plasma concentrations of endogenous inhibitor of nitric oxide synthesis in normal pregnancy and preeclampsia. Lancet 1993;342:242-3.
13. Molnar M, Suto T, Toth T, Hertelendy F. Prolonged blockade of nitric oxide synthesis in gravid rats produces sustained hypertension, proteinuria, thrombocytopenia, and intrauterine growth retardation. Am J Obstet Gynecol 1994;170:1458-66.
14. Yallampalli CH, Garfield RE. Inhibition of nitric oxide synthesis in rats during pregnancy produces signs similar to those of preeclampsia. Am J Obstet Gynecol 1993;169:1316-20.
15. Molnar M, Hertelendy F. N omega-nitro-L-arginine, an inhibitor of nitric oxide synthesis, increases blood pressure in rats and reverses the pregnancy-induced refractoriness to vasopressor agents. Am J Obstet Gynecol 1992;166:1560-7.
16. Neri I, Di Renzo GC, Caserta G, Gallinelli A, Facchinetti F. Impact of the L-arginine/ nitric oxide system in pregnancy. Obstet Gynecol Surv 1995;50:851-8.
17. Jeske W, Soszynski P, Lukaszewicz E, Debski R, Latoszewska W, Rogozinski W, et al. Enhancement of plasma corticotropin-releasing hormone in pregnancy-induced hypertension. Acta Endocrinologica 1990;122:711-4.
18. Ruth V, Hallman M, Laatikainen T. Corticotropin-releasing hormone and cortisol in cord plasma in relation to gestational age, labor and fetal distress. Am J Perinatol 1993;10:115-8.
19. Sasaki A., Sinkawa O., Margioris AN, Liotta AS, Sato S, Murakami O, et al. Immunoreactive corticotrophin-releasing hormone in human plasma during pregnancy, labour and delivery. J Clin Endocrinol Metab 1987;64:224-9.
20. Campbell EA, Linton EA, Wolfe C, Scraggs PR, Jones MT, Lowry PJ. Plasma corticotropin-releasing hormone concentrations during pregnancy and parturition. J Clin Endocrinol Metab 1987;64:1054-9.
21. Frim DM, Emanuel RL, Robinson BG, Smas CM, Alder GK, Majzoub JA. Characterization and gestational regulation of corticotropin-releasing hormone messenger RNA in human placenta. J Clin Invest 1988;82:287-92.
22. Quartero HWP, Fry CH. Placental corticotropin releasing factor may modulate human parturition. Placenta 1989;10:439-43.
23. McLean M, Bisits A, Davies J, Lowry P, Smith, R. A placental clock controlling the length of pregnancy. Nature Medicine 1995;1:460-3.
24. Clifton VL, Read MA, Leitch IM, Giles WG, Boura ALA, Robinson, P, et al. Corticotropin-releasing hormone-induced vasodilatation in the human fetal placental circulation: involvement of the nitric oxide-cyclic guanosine 3′,5′-monophosphatemediated pathway. J Clin Endo Metab 1995;80:2888-93.
25. Petraglia F, Sawchenko PE, Rivier J, Vale W. Evidence for local stimulation of ACTH secretion by corticotropin-releasing factor in human placenta. Nature 1987;328:719-9.
26. Myatt L, Brockman DE, Eis ALW, Pollack JS. Immunohistochemical localization of nitric oxide synthase in the human placenta. Placenta 1993;14:487-95.
27. Riley SC, Walton JC, Herlick JM, Challis JRG. The localization, and distribution of corticotropin-releasing hormone in the human placenta and fetal membranes through-out gestation. J Clin Endocrinol Metab 1991;72:1001-7.
28. Eis AL, Brockman DE, Pollack JS, Myatt L. Immunohistochemical localization of endothelial nitric oxide synthase in human villous and extravillous trophoblast populations and expression during syncytiotrophoblast formation in vitro. Placenta 1995; 16:113-26.
29. Leitch IM, Read MA, Boura ALA, Walters WAW. Effect of inhibition of nitric oxide synthase and guanylate cyclase on hydralazine-induced vasodilatation of the human fetal placental circulation. Clin Exp Pharmacol Physiol 1994;21:615-22.
30. Roe CM, Leitch IM, Boura ALA, Smith R. Nitric oxide regulation of corticotrophin-releasing hormone release from the human perfused placenta in vitro. J Clin Endo Metab 1996,81:763-9.
31. Sokal RR, Rohlf FG. Biometry. The Principles and Practice of Statistics in Biological Research. 2nd ed. San Francisco: W.H. Freeman and Co., 1981:209-70.
32. Rees DD, Palmer RM, Schultz R, Hodson HF, Moncada S. Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. Br J Pharmacol 1990;101:746-52.
33. Myatt L, Brewer A, Brockman DE. The action of nitric oxide in the perfused human fetal-placental circulation. Am J Obstet Gynecol 1991;164:687-92.
34. Gude NM, King RG, Brennecke SP. Role of endothelium-derived nitric oxide in the maintenance of low fetal vascular resistance in placenta. Lancet 1990;336:1589-90.
35. Gonzales C, Cruz MA, Gallardo V, Lagos M, Varela J, Albornoz J, et al. Nitric oxide and prostaglandin systems inhibition on the isolated perfused human placenta from normal and preeclamptic pregnancies. Gynecol Obstet Invest 1995;40:244-8.
36. Hishikawa K, Nakaki T, Suzuki H, Saruta T, Kato R. L-arginine-induced hypotension. Lancet 1991;337:683-4.
37. Hishikawa K, Nakaki T, Suzuki H, Kato R, Saruta T. L-arginine as a antihypertensive agent. J Cardiovasc Pharmacol 1992;20:S196-7.
38. Sun K, Smith R, Robinson PJ. Basal and KCI-stimulated corticotropin-releasing hormone release from human placental syncytiotrophoblasts is inhibited by sodium nitroprusside. J Clin Endocrinol Metab 1994;79:519-24.
39. Cetin I, Marconi AM, Corbetta C, Baggiani AM, Battaglia FC, Pardi G. Fetalmaternal amino acid relationships in normal and intrauterine growth retarded (IUGR) pregnancies. Trophoblast Research 1993;7:11-23.
40. Barnardini I, Evans MI, Nicolaides KH, Economides DL, Gahl WA. The fetal concentrating index as a gestational age-independent measure of placental dysfunction in intrauterine growth retardation. Am J Obstet Gynecol 1991;164:1481-90.
41. Enders RH, Judd RM, Donohue TM, Smith CH. Placental amino acid uptake. III. Transport systems for neutral amino acids. Am J Physiol 1976;230:706-10.
42. Yuldilevich DL, Sweiry JH. Transport of amino acids in the placenta. Biochimica et Biophysica Acta 1985;822:169-201.
43. Giles WB, McClean M, Davies JJ, Smith R. Abnormal umbilical artery doppler waveforms and cord blood corticotropin-releasing hormone. Obstet Gynecol 1996; 87:107-11.
44. Potter E, Behan DP, Fischer WH, Linton EA, Lowry PJ, Vale WW. Cloning and characterization of the cDNAs for human and rat corticotropin-releasing factor-binding proteins. Nature 1991;349:423-6.
45. Goland RS, Jozak S, Conwell I. Placental corticotropin-releasing hormone and hypercortisolism of pregnancy. Am J Obset Gynecol 1994;171:1287-91.
46. Perkins AV, Linton EA, Eben F, Simpson J, Wolfe CD, Redman CW. Corticotropin-releasing hormone and corticotropin-releasing hormone binding protein in normal and pre-eclamptic human pregnancies. Br J Obstet Gynaecol 1995;102:118-22.